Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens

Clicks: 233
ID: 268994
2002
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
This study evaluated whether trimethoprim-sulfamethoxazole (TMP-SMX) is effective for treatment of uncomplicated urinary tract infections (UTIs) due to TMP-SMX-resistant (TMP-SMX-R) pathogens. Healthy nonpregnant premenopausal women with symptomatic lower UTI were assessed for the presence of pyuria ā€¦
Reference Key
r2002clinicalempiric Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Raz R;Chazan B;Kennes Y;Colodner R;Rottensterich E;Dan M;Lavi I;Stamm W; ;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2002
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11941541
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female middle aged drug resistance anti-infective agents trimethoprim bacterial / genetics r raz sulfamethoxazole drug combination / therapeutic use* urinary tract infections / drug therapy* women urinary / therapeutic use* investigators=[] affs=[]) pmid:11941541 doi:10.1086/339812 b chazan collabauthor(name='israeli urinary tract infection group' cystitis / drug therapy gene frequency premenopause

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.